Aggressiveness of cancer-care near the end-of-life in Korea

Japanese Journal of Clinical Oncology

Volumn 38, Issue 5, 2008, Pages 381-386

  Keam, Bhumsuk ^a   Oh, Do Youn ^a   Lee, Se Hoon ^a   Kim, Dong Wan ^a   Kim, Mi Ra ^a   Im, Seock Ah ^a   Kim, Tae You ^a   Bang, Yung Jue ^a   Heo, Dae Seog ^a,b  

^a Seoul National University Hospital   (South Korea)

^b Seoul National University College of Medicine   (South Korea)

Author keywords

Aggressiveness; End of life; Hospice; Palliative chemotherapy

Indexed keywords

ANTINEOPLASTIC AGENT;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER PALLIATIVE THERAPY; CANCER PATIENT; CANCER SURVIVAL; COHORT ANALYSIS; CONSULTATION; EMERGENCY CARE; FEMALE; HOSPICE; HUMAN; KOREA; LIVING WILL; MAJOR CLINICAL STUDY; MALE; NEOPLASM; OVERALL SURVIVAL; PATIENT REFERRAL; RETROSPECTIVE STUDY; TERMINAL CARE; TERMINALLY ILL PATIENT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CANCER CARE FACILITIES; EMERGENCY SERVICE, HOSPITAL; FEMALE; HUMANS; KOREA; MALE; MIDDLE AGED; NEOPLASMS; PALLIATIVE CARE; SURVIVAL ANALYSIS; TERMINAL CARE; WITHHOLDING TREATMENT;

EID: 44449117913     PISSN: 03682811     EISSN: 14653621     Source Type: Journal    
DOI: 10.1093/jjco/hyn031     Document Type: Article

References (27)

1. Earle CC, Neville BA, Landrum MB. Ayanian JZ, Block SD, Weeks JC. Trends in the aggressiveness of cancer care near the end of life. J Clin Oncol 2004;22:315-21.
2. Kurowski B. Cancer carve outs, specialty networks, and disease management: A review of their evolution, effectiveness, and prognosis. Am J Manag Care 1998;4:SP71-89.
3. Oh DY, Kim JE, Lee CH, Lim JS, Jung KH, Heo DS, et al. Discrepancies among patients, family members, and Physicians in Korea in terms of values regarding the withholding of treatment from patients with terminal malignancies. Cancer 2004;100:1961-6.
4. Ngo-Metzger Q, McCarthy EP, Burns RB, Davis RB, Li FP, Phillips RS. Older Asian Americans and Pacific Islanders dying of cancer rise hospice less frequently than older white patients. Am J Med 2003;115:47-53.
5. Barbera L, Paszat L, Chartier C. Indicators of poor quality end-of-life cancer care in Ontario. J Palliat Care 2006;22:12-7.
6. Burge F, Lawson B, Johnston G. Family physician continuity of care and emergency department use in end-of-life cancer care. Med Care 2003:41:992-1001.
7. Mortenson LE. How to judge the cancer services benefit component of your health insurance plan. Cancer 1998;82:2061-7.
8. Kiefe CI, Weissman NW, Allison JJ, Farmer R, Weaver M, Williams OD. Identifying achievable benchmarks of care: Concepts and methodology. Int J Qual Health Care 1998;10:443-7.
9. Korea National Statistical Office. Annual report on the cause of death statistics, 2002-2006.
10. Chen H, Haley WE, Robinson BE, Schonwetter RS. Decisions for hospice care in patients with advanced cancer. J Am Geriatr Soc 2003;51:789-97.
11. Emanuel EJ, Young-Xu Y, Levinsky NG, Gazelle G, Saynina O, Ash AS. Chemotherapy use among Medicare beneficiaries at the end of life. Ann Intern Med 2003;138:639-43.
12. Gagnon B, Mayo NE, Hanley J, MacDonald N. Pattern of care at the end of life: Does age make a difference in what happens to women with breast cancer? J Clin Oncol 2004;22:3458-65.
13. Martoni AA, Tanneberger S, Mutri V. Cancer chemotherapy near the end of life: The time has come to set guidelines for its appropriate use. Tumori 2007;93:417-22.
14. Earle CC, Venditti LN, Neumann PJ, Gelber RD, Weinstein MC, Potosky AL, et al. Who gets chemotherapy for metastatic lung cancer? Chest 2000;117:1239-46.
15. Kearney N, Miller M, Paul J, Smith K. Oncology healthcare professionals' attitudes toward elderly people. Ann Oncol 2000;11: 599-601.
16. Yun YH, Lee CG, Kim SY, Lee SW, Heo DS, Kim JS. et al. The attitudes of cancer patients and their families toward the disclosure of terminal illness. J Clin Oncol 2004;22:307-14.
17. Holroyd EE. Chinese family obligations toward chronically ill elderly members: Comparing caregivers in Beijing and Hong Kong. Qual Health Res 2003;13:302-18.
18. Tang ST, Liu TW, Lai MS, Liu LN, Chen CH. Concordance of preferences for end-of-life care between terminally ill cancer patients and their family caregivers in Taiwan. J Pain Symptom Manage 2005:30:510-8.
19. Lim JH, Choi KS, Kim SG, Park EC, Park JH. Effects of private health insurance on health care utilization and expenditures in Korean cancer patients: Focused on 5 major cancers in one cancer center. J Prev Med Pub Health 2007;40:329-35.
20. Fireman BH, Quesenberry CP, Somkin CP, Jacobson AS, Baer D, West D, et al. Cost of care for cancer in a health maintenance organization. Health Care Finance Rev 1997;18:51-76.
21. Chirikos TN. Cancer economics: On variations in the costs of treating cancer. Cancer Control 2002;9:59-66.
22. Wennberg JE, Fisher ES, Stukel TA, Skinner JS, Sharp SM, Bronner KK. Use of hospitals, physician visits, and hospice care during last six months of life among cohorts loyal to highly respected hospitals in the United States. BMJ 2004;328:607.
23. Bruera E, Russell N, Sweeney C, Fisch M, Palmer JL. Place of death and its predictors for local patients registered at a comprehensive cancer center. J Clin Oncol 2002,20:2127-33.
24. Virnig BA, Fisher ES, McBean AM, Kind S. Hospice use in Medicare managed care and fee-for-service systems. Am J Manag Care 2001;7:777-86.
25. Travers DA, Mears G. Physicians' experiences with prehospital do-not-resuscitate orders in North Carolina. Prehospital Disaster Med 1996;11:91-100.
26. Hinkka H, Kosunen E, Metsanoja R, Lammi UK, Kellokumpu-Lehtinen P. To resuscitate or not: A dilemma in terminal cancer care. Resuscitation 2001;49:289-97.
27. Oh DY, Kim JH, Kim DW, Im SA, Kim TY, Heo DS, et al. CPR or DNR? End-of-life decision in Korean cancer patients: A single center's experience. Support Care Cancer 2006;14:103-8.